Vicore Pharma Holding AB (publ)

OM:VICO Stock Report

Market Cap: SEK 877.1m

Vicore Pharma Holding Balance Sheet Health

Financial Health criteria checks 6/6

Vicore Pharma Holding has a total shareholder equity of SEK435.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK478.7M and SEK43.8M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 466.44m
EquitySEK 434.98m
Total liabilitiesSEK 43.75m
Total assetsSEK 478.73m

Recent financial health updates

Recent updates

We're Not Very Worried About Vicore Pharma Holding's (STO:VICO) Cash Burn Rate

Sep 11
We're Not Very Worried About Vicore Pharma Holding's (STO:VICO) Cash Burn Rate

Vicore Pharma Holding (STO:VICO) Is In A Good Position To Deliver On Growth Plans

Feb 10
Vicore Pharma Holding (STO:VICO) Is In A Good Position To Deliver On Growth Plans

We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

Sep 21
We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

May 25
We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

Calculating The Intrinsic Value Of Vicore Pharma Holding AB (publ) (STO:VICO)

Jan 10
Calculating The Intrinsic Value Of Vicore Pharma Holding AB (publ) (STO:VICO)

Is Vicore Pharma Holding (STO:VICO) In A Good Position To Invest In Growth?

Nov 13
Is Vicore Pharma Holding (STO:VICO) In A Good Position To Invest In Growth?

Here's Why We're Watching Vicore Pharma Holding's (STO:VICO) Cash Burn Situation

Jul 26
Here's Why We're Watching Vicore Pharma Holding's (STO:VICO) Cash Burn Situation

Is Vicore Pharma Holding AB (publ) (STO:VICO) Worth kr17.6 Based On Its Intrinsic Value?

Mar 03
Is Vicore Pharma Holding AB (publ) (STO:VICO) Worth kr17.6 Based On Its Intrinsic Value?

What You Need To Know About Vicore Pharma Holding AB (publ)'s (STO:VICO) Investor Composition

Jan 11
What You Need To Know About Vicore Pharma Holding AB (publ)'s (STO:VICO) Investor Composition

Financial Position Analysis

Short Term Liabilities: VICO's short term assets (SEK478.2M) exceed its short term liabilities (SEK39.9M).

Long Term Liabilities: VICO's short term assets (SEK478.2M) exceed its long term liabilities (SEK3.8M).


Debt to Equity History and Analysis

Debt Level: VICO is debt free.

Reducing Debt: VICO had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VICO has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: VICO has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 26.4% each year.


Discover healthy companies